Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isoniazid interactions.

A M Baciewicz, T H Self

    Southern Medical Journal
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Isoniazid is a tuberculosis drug that can interact with other medications by inhibiting their metabolism. Further research is needed to fully understand these drug interactions and their clinical significance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical management.

    Journal of clinical pharmacy and therapeutics·2017
    Same author

    Are there gender differences in the use of peak flow meters?

    The Journal of asthma : official journal of the Association for the Care of Asthma·2001
    Same author

    Bleeding associated with doxycycline and warfarin treatment.

    Archives of internal medicine·2001
    Same author

    Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

    Drugs·2001
    Same author

    Studies demonstrating improved outcomes in patients with asthma: a 10-year review.

    The American journal of managed care·2001
    Same author

    Hospital admission due to warfarin potentiation by TMP-SMX.

    The Nurse practitioner·2001
    Same journal

    SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

    Southern medical journal·2026
    Same journal

    Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

    Southern medical journal·2026
    Same journal

    Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

    Southern medical journal·2026
    Same journal

    Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

    Southern medical journal·2026
    Same journal

    Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

    Southern medical journal·2026
    Same journal

    Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Drug Metabolism
    • Tuberculosis Treatment

    Background:

    • Isoniazid is a primary antitubercular medication.
    • It is typically prescribed for 9-12 months.
    • Isoniazid is known to inhibit drug metabolism.

    Purpose of the Study:

    • To review the known drug interactions of isoniazid.
    • To highlight the clinical significance of isoniazid's metabolic inhibition.
    • To identify areas for future research on isoniazid interactions.

    Main Methods:

    • Literature review of studies and case reports.
    • Analysis of documented isoniazid drug interactions.
    • Identification of enzyme inhibition pathways affected by isoniazid.

    Related Experiment Videos

    Main Results:

    • Isoniazid inhibits the metabolism of drugs like phenytoin, carbamazepine, anticoagulants, and benzodiazepines.
    • It also affects vitamin D metabolism.
    • Isoniazid inhibits monoamine oxidase and diamine oxidase (histaminase).

    Conclusions:

    • Isoniazid's potent enzyme inhibition poses a risk for clinically significant drug interactions.
    • Further investigation is required to fully elucidate the scope and impact of these interactions.
    • Future studies are expected to uncover additional isoniazid-related drug interactions.